Prestige V with Havlogen (Canada)

This page contains information on Prestige V with Havlogen for veterinary use.
The information provided typically includes the following:
  • Prestige V with Havlogen Indications
  • Warnings and cautions for Prestige V with Havlogen
  • Direction and dosage information for Prestige V with Havlogen

Prestige V with Havlogen

This treatment applies to the following species:
Manufacturer: Merck Animal Health

Equine Vaccine

ENCEPHALOMYELITIS - RHINOPNEUMONITIS - INFLUENZA VACCINE

EASTERN AND WESTERN, KILLED VIRUS

TETANUS TOXOID

A combination of inactivated, purified, concentrated, adjuvanted, tissue culture origin Equine Encephalomyelitis Virus, Eastern and Western, Equine Herpesviruses EHV-1 and EHV-4, Equine Influenza Virus subtype A2 including KY93, KY02, and NM2/93 strains and Tetanus Toxoid. Intervet serological data suggest Influenza cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 03, Newmarket/1/93, Newmarket/2/93, Suffolk 89, and South Africa 03.

Prestige V with Havlogen Indications

For vaccination of healthy horses, 6 months of age or older, as an aid in the prevention of Eastern and Western Encephalomyelitis and Tetanus, as an aid in the control of respiratory disease caused by Equine Influenza Virus and Equine Herpesvirus and as an aid in the reduction of Influenza virus shedding. Duration of Immunity (DOI) has been shown to be at least 6 months for Influenza. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

DOSE: For primary immunization aseptically inject 1 mL intramuscularly and repeat the dose in 3 to 4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

CAUTIONS: Store at 2° to 7°C (35° to 45°F). Shake well before using. Use entire contents when first opened (10 doses). Do not vaccinate within 21 days before slaughter. Local reactions may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactoid reactions may occur.

CAUTION: Needle is sharp and may cause injury to self or animals if not handled properly or disposed of properly.

ANTIDOTE: Epinephrine.

Thimerosal added as preservative.

*Adjuvant-Intervet's Proprietary Technology.

FOR USE IN ANIMALS ONLY

Intervet Inc., Millsboro, DE 19966

For technical enquiries, call toll free 1 888 306-0069.

U.S. Vet. License No. 165A

 

 

PRODUCT CODE

 

10 Doses

Ten 1 mL Syringes with Separate Sterile Needles

036486

09990101

10 Doses

10 mL

036595

09991001

NAC No.: 12081752

MERCK ANIMAL HEALTH
Intervet Canada Corp.

16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7
Order Desk:   514-428-7013
Toll-Free:   866-683-7838
Fax:   Toll-free 888-498-4444; local 514-428-7014
Website:   www.merck-animal-health.ca
Every effort has been made to ensure the accuracy of the Prestige V with Havlogen information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-05-28

(web1)